DSIP (Delta Sleep-Inducing Peptide) is an endogenous nonapeptide first isolated from rabbit brain in 1977. Its amino acid sequence is Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu. It modulates sleep architecture and has additional roles in stress response and pain modulation.

DSIP modulates sleep by influencing GABAergic and glutamatergic neurotransmission, lowering cortisol and CRH levels, and promoting delta wave (slow-wave) sleep stages. It also interacts with opioid systems for analgesic effects.

Is DSIP FDA approved?

No. DSIP is not approved by the FDA or any major regulatory agency. It remains an investigational peptide used in research settings.

What dose is used in research?

Clinical studies have used intravenous doses of 25 nmol/kg body weight. Subcutaneous protocols in research settings typically range from 100-300 mcg before bedtime.

Does DSIP have side effects?

DSIP is generally reported as well-tolerated in clinical studies. Some subjects report transient morning grogginess. Long-term safety data is limited.

Can DSIP help with insomnia?

Double-blind studies in chronic insomniacs showed improved sleep efficiency and increased slow-wave sleep. However, results are mixed and larger trials are needed to confirm efficacy.

Sleep Peptide • Endogenous Nonapeptide

DSIP: The Sleep-Inducing Peptide

By MeetPeptide Research Team

Last updated: March 2026

Delta Sleep-Inducing Peptide is a naturally occurring nonapeptide first isolated from rabbit cerebral venous blood in 1977. It modulates sleep architecture, stress response, and has analgesic properties studied across multiple clinical trials.

Amino Acid
Sequence Length

Year First
Isolated

Clinical Study
IV Dose

Background

What Is DSIP?

DSIP (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) is an endogenous nonapeptide discovered by Schoenenberger and Monnier. Unlike most sleep aids, it doesn't cause sedation — it modulates the natural sleep cycle by promoting delta-wave (slow-wave) sleep stages.

🌙

Sleep Architecture Modulation

Promotes delta-wave (slow-wave) sleep without sedative effects. Modulates the natural sleep-wake cycle rather than forcing unconsciousness like traditional hypnotics.

🧠

Neuroendocrine Regulation

Reduces cortisol and corticotropin-releasing hormone (CRH) levels. Modulates LH and GH secretion patterns, acting as a broad neuroendocrine modulator.

💊

Analgesic Properties

Interacts with opioid receptor systems to produce analgesic effects. Clinical studies showed significant pain reduction in chronic pain patients over 5-10 day treatment courses.

🛡️

Stress Response

Exhibits stress-protective properties by modulating the HPA axis. Research suggests DSIP can limit the adrenal cortex response to ACTH stimulation under stress conditions.

Research

What the Research Shows

📋

Context: DSIP has been studied in double-blind placebo-controlled trials since the 1980s. Results on sleep are promising but mixed — some trials show significant improvement while others are inconclusive. The analgesic data is more consistently positive.

Chronic Insomnia — Double-Blind Study (16 patients)

Improved sleep efficiency and increased slow-wave sleep vs placebo over 5 nights

Mixed

Chronic Pain — Clinical Pilot (7 patients)

Significant pain reduction in 6/7 patients after IV administration over 5 consecutive days

Positive

Acute and Delayed Sleep Effects — Crossover Design

25 nmol/kg IV infusion showed acute sleep-promoting effects on slow-wave parameters

Positive

Withdrawal Symptom Management

Reports of DSIP aiding opioid and alcohol withdrawal symptoms in observational studies

Preliminary

Safety

Side Effects & Safety Profile

Morning Grogginess

Transient drowsiness reported in some subjects

Mild

Injection Site Reactions

Minor redness or irritation at injection site

Mild

Long-term Safety Data

No comprehensive long-term safety studies published

Unknown

Sources

Study Citations

Clinical Trial

Effects of delta sleep-inducing peptide on sleep of chronic insomniac patients. A double-blind study

Schneider-Helmert D. · Neuropsychobiology, 1987 · PMID: 3583493

Clinical Pilot

Therapeutic effects of delta-sleep-inducing peptide (DSIP) in patients with chronic, pronounced pain episodes

Larbig W, et al. · European Neurology, 1984 · PMID: 6548970

Crossover Study

Acute and delayed effects of DSIP on human sleep behavior

Schneider-Helmert D, Schoenenberger GA. · International Journal of Peptide and Protein Research, 1983 · PMID: 6895513

Double-Blind Study

Effects of delta sleep-inducing peptide on sleep of chronic insomniac patients

Schneider-Helmert D. · Neuropsychobiology, 1992 · PMID: 1299794

Self-Assessment

Who Researches DSIP?

This Research Is Commonly Explored By People Who...

Are investigating peptide-based approaches to sleep optimization without traditional sedatives
Want to understand endogenous sleep-regulating peptides and their mechanisms
Are interested in the connection between sleep architecture, pain, and neuroendocrine function
Are exploring alternatives for stress-related sleep disturbances

This Research May Not Be Relevant If...

You expect immediate knockout-style sedation — DSIP modulates sleep architecture, not consciousness
You want well-established long-term safety data — it doesn't exist for DSIP
You need FDA-approved options — DSIP remains investigational

📚

Want the Complete Protocol Guide?

Dosing schedules, interaction warnings, and cycle protocols for 50+ compounds — all in one place.

Get the Guide →

⚕️ Disclaimer: This is educational content, not medical advice. Always consult a healthcare provider before making decisions about your health.

Bottom Line

Key Takeaways

✅ What We Know

Endogenous nonapeptide discovered in 1977
Promotes delta-wave sleep without sedation
Analgesic effects confirmed in clinical pilot
Modulates cortisol and stress response
Generally well-tolerated in short-term studies

⚠️ What We Don't Know

Not FDA approved — investigational only
Sleep results are mixed across trials
No long-term safety data available
Exact receptor binding profile still debated
Optimal dosing protocol not established

🔬 Verified Research Source

Third-party tested compounds from Swiss Chems — one of the most trusted research suppliers.

🧬 DSIP (Delta Sleep-Inducing Peptide) Buy from Swiss Chems — Lab-tested, verified purity → Shop Now

Affiliate link — supports MeetPeptide at no extra cost. All Swiss Chems products include third-party lab testing certificates.